Meloxicam | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Meloxicam
USP

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Meloxicam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 22 USDMF, 15 CEP/COS, 7 JDMF, 15 EU WC, 27 KDMF, 20 NDC API, 34 Listed Suppliers, $ API Reference Price

56 API Suppliers
22 USDMF
15 CEP/COS
7 JDMF
15 EU WC
27 KDMF
20 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

INTERMEDIATES

13 Intermediates Suppliers

13 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

324 FDF Dossiers, 62 FDA Orange Book, 69 Europe, 36 Canada, 34 Australia, 44 South Africa, 79 Listed Dossiers

324 FDF Dossiers
62 FDA Orange Book
69 Europe
36 Canada
34 Australia
44 South Africa
79 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML

TABLET;ORAL - 15MG
TABLET;ORAL - 7.5MG
SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 8 SPI Pharma, 11 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Actylis, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 7 DFE Pharma, 7 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qualicaps, 27 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 43 Disintegrants & Superdisintegrants, 41 Direct Compression, 26 Granulation, 25 Thickeners and Stabilizers, 21 Lubricants & Glidants, 19 Co-Processed Excipients, 17 Coating Systems & Additives, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 13 Controlled & Modified Release, 12 Film Formers & Plasticizers, 10 Solubilizers, 9 Parenteral, 8 Empty Capsules, 7 Topical, 5 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

78 Fillers, Diluents & Binders
43 Disintegrants & Superdisintegrants
41 Direct Compression
26 Granulation
25 Thickeners and Stabilizers
21 Lubricants & Glidants
19 Co-Processed Excipients
17 Coating Systems & Additives
16 Taste Masking
14 Chewable & Orodispersible Aids
13 Controlled & Modified Release
12 Film Formers & Plasticizers
10 Solubilizers
9 Parenteral
8 Empty Capsules
7 Topical
5 Rheology Modifiers
4 Emulsifying Agents
3 API Stability Enhancers
2 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 46 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
46 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 57 Finished Drug Prices, 1 Annual Reports

3 US Medicaid Prescriptions
57 Finished Drug Prices
1 Annual Reports

MARKET PLACE

34 APIs, 2 FDF Dossiers, 1 Intermediates

34 APIs
2 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

81 US Patents, 8 US Exclusivities, 2 Health Canada Patents

81 US Patents
8 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 6 USP, 6 Others

5 EDQM
6 USP
6 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 94 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

6 All

01 11379401

02 11379412

03 11379423

04 11379434

05 11379445

06 11379456

filter Description Reset all filters

6 All

01 1(Z)-N'-Methylmeloxicam (30 mg) ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide)

02 14-Methoxymeloxicam (30 mg) (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide)

03 1Meloxicam (400 mg)

04 1Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide)

05 1Meloxicam Related Compound B (25 mg) (5-Methylthiazol-2-amine)

06 1Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide)

filter CAS Number Reset all filters

6 All

01 11145656-36-5

02 124683-26-9

03 171125-38-7

04 17305-71-7

05 2N/A

Product Main Page

01

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

(Z)-N'-Methylmeloxicam (30 mg) ((Z)-N-(3,5-di...

CAS Number : 1145656-36-5

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1379456

Current Lot : F0L249

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

4-Methoxymeloxicam (30 mg) (4-methoxy-2-methy...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1379445

Current Lot : G0L252

Previous Lot : F0E160

NDC Code :

Product Web Link

Digital Content

03

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam Related Compound C (30 mg) (Isoprop...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1379434

Current Lot : R068M0

Previous Lot : G1J196 (28-FEB-2018)

NDC Code :

Product Web Link

Digital Content

04

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam Related Compound B (25 mg) (5-Methy...

CAS Number : 7305-71-7

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1379423

Current Lot : H1K353

Previous Lot : H0K353 (30-JUN-2017)

NDC Code :

Product Web Link

Digital Content

05

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam Related Compound A (25 mg) (ethyl-4...

CAS Number : 24683-26-9

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1379412

Current Lot : G1J238

Previous Lot : G0J238 (30-JUN-2015)

NDC Code :

Product Web Link

Digital Content

06

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam (400 mg)

CAS Number : 71125-38-7

Quantity Per Vial :

Price ($) : 385

Catalog Number : 1379401

Current Lot : R02670

Previous Lot : H0J100 (28-FEB-2017)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?